Axiom biobank brochure

1. Exome SNPs
and indels
Newly discovered
loss-of-function
content
Common
variant GWAS
imputation grid
eQTLs
Variants of
your choosing
Pharmacogenomic
markers
n Designed by and for thought leaders in the human genetics community for high-throughput, highly powered causal
variant studies at an affordable price
n Over 600,000 total variants including the ability to add 115,000 variants of your choosing
n Common variants for GWAS analysis, resulting in high coverage in major 1000 Genomes populations
n Newly discovered coding and loss-of-function variants identified from 26,000 exome re-sequencing initiative
n High representation of rare variants: over 330,000 variants with MAF <1%, including thousands of indels
n Intelligent marker selection enables imputation of millions of additional SNPs
For more information, visit www.affymetrix.com/axiombiobank.
Axiom® Biobank Genotyping Arrays
Power large sample studies with high-value genotyping
Genotype large sample cohorts to explore genetics of complex diseases with
a single comprehensive, low-cost,high-throughput solution.
Axiom®
Genotyping Solution
Redefine what’s possible
“For Research Use Only. Not for use in diagnostic procedures.”
P/N DNA01729-5 ©Affymetrix Inc., All rights reserved.